NVO Competitors & Alternatives
Compare Novo Nordisk A/S with similar stocks in the same industry
Drug Manufacturers - General
NVO
Main Stock$47.49
Tradestie Score
55
Market Cap
$262.92B
P/E Ratio
10.9
Revenue Growth
0.2%
Analyst Upside
-1.4%
Top Competitors
20 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
UNH
UNITEDHEALTH GROUP INCORPORATED (Delaware)
|
$406.20
|
$315.45B | 30.6 | 55 | Compare |
|
AZN
AstraZeneca PLC
|
$182.97
|
$261.56B | 27.2 | 51 | Compare |
|
NVS
Novartis AG
|
$153.24
|
$254.99B | 21.3 | 59 | Compare |
|
MRK
Merck & Co., Inc.
|
$120.03
|
$225.13B | 32.5 | 59 | Compare |
|
AMGN
Amgen Inc
|
$352.40
|
$160.70B | 24.0 | 64 | Compare |
|
PFE
Pfizer Inc.
|
$24.27
|
$154.70B | 19.1 | 59 | Compare |
|
GILD
Gilead Sciences Inc
|
$125.39
|
$137.92B | 17.0 | 56 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$41.62
|
$121.27B | 18.4 | 57 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$55.09
|
$96.54B | 15.3 | 56 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$51.46
|
$91.59B | 13.5 | 57 | Compare |
More NVO Analysis
Data updated: Jun 24, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
20 stocks in this industry